eHN value set changes v1.15

Changes:

• Update to eHN guidelines document for value sets, version 1.15:

  1. New vaccine entry added: “Bimervax“, ID'd as “EU/1/22/1709”.
     This new entry does not have an explicit version because it's an EMA-approved vaccine, and EMA has their own versioning system.
  2. Addition of a marketing authorization holder or manufacturer “Hipra Human Health S.L.” for the new vaccine entry, ID'd as “ORG-100036914”.
  3. Addition of a vaccine encoding instruction corresponding to the combination of sub items 1 and 2.

  The guidelines document v1.15 has been adopted and published through the eHealth network page on the EU DCC.

• Implement validation of valuesets against the EU DCC Schema.

  • Implement a Git hook that runs that validation prior to committing.

• Improve the documentation - README an VERSIONING - in various ways.

  • Fix not-yet-renamed links to repos which formerly were prefixed with "ehn-dcc-".

eHN value set changes v1.14

Changes:

• Add a value set that encodes Annex A of the guidelines document, including its derivation. See the README for more details.
• W.r.t. the "COVID-19 vaccine or prophylaxis" value set, corresponding to the table in § 2.2 in the guidelines document:
  • The "J07BX03" ACT code has been deprecated by setting its active field's value to false and adding a postfix (deprecated) to the display field's value.
  • The first two entries, for codes "1119349007" and "1119305005", have been swapped to match the order in the document's table.
  • Entries for SCT codes "28531000087107" (which replaces the "J07BX03" ACT code), "30141000087107", and "1187593009" have been added.
• W.r.t. to the "vaccine encoding instructions" value set, corresponding to Annex A of the guidelines document:
  • All occurrences of the "J07BX03" ACT code in , have been replaced by the "28531000087107" SCT code.
  • The derivation script for this value set has been updated to check for deprecated ACT/SCT codes. (It also reports the correct row numbers now.)

The guidelines document v1.14 has been adopted and published through the eHealth network page on the EU DCC.

eHN value set changes v1.13

Changes:

• Update to eHN guidelines document for value sets, version 1.13:

  1. New vaccine entry added: “VidPrevtyn Beta“, ID'd as “EU/1/21/1580”, and previously known as “Vidprevtyn” (which is both its display name and its ID).
     This new entry does not have an explicit version because it's an EMA-approved vaccine, and EMA has their own versioning system.
  2. Existing vaccine ID'd as “Vidprevtyn” has been deprecated.
     This is expressed in the corresponding entry in the vaccines-covid-19-names value set by:
     • Adding the postfix (deprecated) to the display field's value;
     • Setting the active field's value to false, indicating that this vaccine ID should not be used anymore for new vaccines.

  The guidelines document v1.13 has been adopted and published through the eHealth network page on the EU DCC.

  Version 1.12 of this document has also been adopted after v1.11, but v1.12 only adds a textual clarification which has no impact on the (implementation of the) value sets themselves, and an Annex B which has been removed again in v1.13.

eHN value set changes v1.11

Changes:

• Update to eHN guidelines document for value sets, version 1.11:

  1. New vaccine entry added: “COVID-19 Vaccine Valneva“, ID'd as “EU/1/21/1624”, and previously known as VLA2001.
     (This entry does not have an explicit version because it's an EMA-approved vaccine, and EMA has their own versioning system.)
  2. Existing vaccine ID as “VLA2001” has been deprecated.
     This is expressed in its entry by:
     • Adding the postfix (deprecated) to the display field's value;
     • Setting the active field's value to false, indicating that this vaccine ID should not be used anymore for new vaccines.

  The guidelines document v1.11 has been adopted and published through the eHealth network page on the EU DCC.

eHN value set changes v1.10

Changes:

• Update to eHN guidelines document for value sets, version 1.10:

  1. Change of the name of one vaccine: Jcovden, formerly known as “COVID-19 Vaccine Janssen”
  2. New vaccines: Soberana 02, and Soberana Plus
  3. New vaccine marketing authorization holder or manufacturer: Finlay-Institute

  The guidelines document v1.10 has been adopted and published through the eHealth network page on the EU DCC.

eHN value set changes v1.9

Changes:

• Update to eHN guidelines document for value sets, version 1.9:

  1. Inclusion of the follow prophylaxes (types):
     • SARS-CoV-2 recombinant spike protein antigen vaccine
     • Inactivated whole SARS-CoV-2 antigen vaccine
     • COVID-19 non-replicating viral vector vaccine
  2. Inclusion of the following vaccines:
     • Covid-19-adsorvida-inativada
     • NVSI-06-08
     • YS-SC2-010
     • SCTV01C
     • Covifenz
     • AZD2816
  3. Inclusion of the following MAH:
     • Instituto Butantan
     • National Vaccine and Serum Institute, China
     • Yisheng Biopharma
     • Sinocelltech Ltd.
     • Medicago Inc.
  4. (Small adjustment to the values of the display name fields for Covaxin and Covishield.)

  The guidelines document v1.9 has been adopted and published through the eHealth network page on the EU DCC.

eHN value set changes v1.8

Changes:

• Update to eHN guidelines document for value sets, version 1.8:

  1. Inclusion of the following vaccines:
     1. Covovax from Serum Institute of India, WHO approved
     2. Sputnik M from Gamaleya-Institute
     3. EpiVacCorona-N from Vector-Institute
     4. Vidprevtyn from Sanofi Pasteur, also in rolling review by EMA
     5. VLA2001 from Valneva France, also in rolling review by EMA
  2. Inclusion of the following MAH:
     1. ORG-100000788 (Sanofi Pasteur)
     2. ORG-100036422 (Valneva France)

  The guidelines document v1.8 has been adopted and published through the eHealth network page on the EU DCC.

eHN value set changes v1.7

Changes:

• Update to eHN guidelines document for value sets, version 1.7:

  1. New vaccine entry added: “Nuvaxovid“, ID'd as “EU/1/21/1618”, and previously known as NVX-CoV2373. (This entry does not have an explicit version because it's an EMA-approved vaccine, and EMA has their own versioning system.)
  2. Existing vaccines “NVX-CoV2373”, and “Inactivated-SARS-CoV-2-Vero-Cell” have been deprecated. This is expressed in their respective entries by:
  • Adding the postfix (deprecated) to the display field's values;
  • Setting the active field's values to false, indicating that these vaccine IDs should not be used anymore for new vaccines.
  3. Value of display field of the vaccine ID'd as EU/1/20/1507 has been shortened to “Spikevax”.
  4. Value of display field of the vaccine manufacturer ID'd as “ORG-100032020” has been corrected to “Novavax CZ a.s.”.

  The guidelines document v1.7 has been adopted and published through the eHealth network page on the EU DCC.

fix release: 2.4.1

Add vaccine NVX-CoV2373 that was previously missing relative to the value sets guidelines document. This release can be considered to be a bug fix of the initial release corresponding to the v1.0 version of the value sets guidelines document. Practically speaking, it can be viewed as a continuation of the previous release corresponding to the v1.6 version of the value sets guidelines document.

eHN value set changes v1.6

• Update to eHN guidelines document for value sets, version 1.6:

  1. New vaccine: “MVC COVID-19 vaccine“, ID'd as “MVC-COV1901”.
  2. New manufacturer (for the new vaccine): “Medigen Vaccine Biologics Corporation”, ID'd as “ORG-100033914”.

  The guidelines document v1.6 has been adopted and published through the eHealth network page on the EU DCC.

• Change the versioning process, and document it in VERSIONING.md.